Metis Neurotec

Our Travels

Swiss market study trip for LifeScience, MedTech and AI

From 07/05 – 07/07/2022, Markus Schinle from Metis Neurotec explored the LifeScience, MedTech and AI market in Switzerland.

The trip to the two top Swiss Life Science/ MedTech locations Basel and Zurich offered the perfect opportunity for us to get to know the highly innovative market in more detail, to get interesting insights, to exchange ideas with experts on site and to make new business connections.

During the 3 days of the program, an exciting and varied program on the topic of life science in Switzerland awaited us. Basel gave us a wonderful welcome. From there the program started with exciting keynotes, visits and talks. We started with a presentation by Daniel Meier from Basel Area Business & Innovation with super interesting information about the Life Science location Basel. It continued with visits to the highly diverse, very innovative and impressive companies Biolytix AG / IES Ltd., ten23 health and Ymmunobio AG! Afterwards we went to Zurich for a networking dinner and an evening full of interesting conversations and networking. In Zurich we were then offered a great program the next day.

Briefly about the life science ecosystem between Germany and Switzerland

The life science ecosystem in the economic areas of Zurich and Basel has developed dynamically in recent years and is becoming increasingly important globally, and therefore also of growing interest to Baden-Württemberg as a location for innovation. Switzerland has long been one of the most important and strongest economic partners of Germany’s southwest. More than a third of all Swiss exports to Germany go to Baden-Württemberg; more than a quarter of Swiss imports from Germany come from the German southwest. Baden-Württemberg and Switzerland also have a long and successful history together as mutual investors and innovation partners. Therefore, one focus is also on strengthening and expanding economic and political relations between Baden-Württemberg and Switzerland.

Sources (aufgerufen am 11.07.2022): BW_i, LinkedIn I, LinkedIn II.


Interview with NEULAND

We were interviewed by the KIT magazine “NEULAND” about our startup Metis Neurotec. In the magazine you can now read what makes our startup so special and which approaches we envision in our treatment concept against dementia.

The symptoms of dementia are painful – for everyone affected. Sooner or later, the increasing mental and physical limitations mean that patients are no longer able to lead independent lives and are dependent on time-consuming and high-cost assistance. Therefore, the disease is also a great burden for relatives.

Our Goal
Optimal treatment planning after diagnosis by the doctor using a digital, AI-supported concept.

The course of dementia is complex, there are different forms with countless risk factors and symptoms. We are developing a fully comprehensive system that records and validates risk factors and treatment approaches. The heart of our AI-powered treatment approach is the METIS app. Accessible via smartphone, it is complemented by wearable sensor technology such as fitness trackers and an EEG device. This allows the patient’s risk levels to be recorded and collected in the app using artificial intelligence, evaluated and automatically transferred into treatment measures. In this way, the course of dementia can be greatly influenced, especially in the early stages, by individual treatment of reversible risk factors such as unhealthy sleep, smoking or lack of social contact, and the progression of dementia can thus be reduced.

Our Engagement Strategy
App on prescription: METIS app in combination with wearable sensor technology.

As a team, we are currently preparing the foundation. Our solution is attracting widespread interest from university clinics, to health insurance companies, to the German Alzheimer Society. The app is currently being tested by pilot patients and further developed. In the medium to long term, we would like to launch the ‘app on prescription’ as a medical product and thus support neurologists, general practitioners and health insurers. In order to obtain approval as a medical product, we are working intensively on the regulations for digital health apps. Now the next important steps towards approval include a clinical trial and certification according to the requirements of the European Medical Device Regulation.

Source of Content:


Metis Neurotec benefits from expertise of the ALFREDO project

Worldwide, only 20-50% of all dementia cases are detected. Yet almost 90% of all physicians and patients surveyed call for early diagnosis in order to be able to respond to associated changes in care and everyday life. One-third of these dementias can be prevented, or the course positively influenced by timely treatment of specific risk factors, thus significantly increasing the patients’ autonomy.

Briefly about ALFREDO

AI-based platform for outpatient early detection and individualized treatment of dementia

The project, funded by the Ministry of Social Affairs of Baden-Württemberg, provides an excellent environment in the research field of telemedicine and health care research to design, develop and validate different tools in the context of the advancing digitalization in gerontological medicine.

The insights generated in this project also shape our further requirements for the system. We are pleased about ALFREDO, as well as all the research funding of comparable projects. We are excited about the results that will pave the way for projects like Metis Neurotec.

Our goal is to provide a fully comprehensive outpatient treatment approach. This way, dementia can be treated in a targeted manner by addressing risk factors and can be made accessible to a large number of people in a very structured way. In this context, Metis Neurotec accompanies professionals and patients from diagnosis to treatment. Through our AI-supported platform for risk factor treatment, physicians can quickly and on an outpatient basis, detect cognitive performance impairments in patients, for example, to detect Alzheimer’s disease at an early stage and treat it in a tailored manner.


Team Introduction: Markus Schinle

Markus Schinle

Markus Schinle has an excellent academic record. His studies focused on the development of information systems, technology management and entrepreneurship and led to a  M. Sc. degree in Information Engineering and Management at KIT in 2015 with stays abroad at TEI Larissa (Greece) and ETH Zurich (Switzerland). In addition to a private sector scholarship from a consultancy in finance, he was awarded twice during his studies by receiving the Deutschlandstipendium (2011/2013) and by being accepted into the SAP FastTrack Program. During his PhD, he was a participant of the Software Campus 2018 Program. Besides practical experience at a management consultancy, he can boast the Certified Project Management Associate (IPMA Level D) certification. Markus is doing his PhD at the KIT-ITIV under supervision of Prof. Stork in the field of data-driven development of medical software applications in neuropsychology.


Team Introduction: Simon Stock

Simon Stock

Simon Stock is doing his PhD at KIT-ITIV  under supervision of Prof. Stork in the field of AI-supported medical technology using brain-computer interfaces. He started a research collaboration with the Massachusetts Institute of Technology. Before that, he specialised in Systems Engineering (M.Sc.) at KIT in the field of electrical engineering. During his studies, he received the Microsoft Studentpartner Scholarship due to his outstanding qualifications in the IT field and was active as a Microsoft Campus Expert. He also published numerous apps for the Microsoft platform. He developed his enthusiasm for start-ups both during his master’s thesis in the San Francisco Bay Area at Zeiss and during his successful participation in international hackathons. In 2020, he was awarded the prestigious faculty teaching prize for the “Laboratory for Applied Machine Learning Algorithms” for his teaching activities.


Team Introduction: Marius Gerdes

Marius Gerdes

Marius Gerdes most recently completed his M. Sc. in Mechanical Engineering at the KIT Karlsruhe Institute of Technology. He gained experience abroad early on through a nine-year stay in Norway. He decided to return to Germany for his mechanical engineering studies. During this time, he became intensively involved with additive manufacturing. He had the opportunity to learn about the chances and risks for start-ups during his work as a student trainee at the start-up Apium Additive Technologies GmbH. Here he was involved in research and development of hardware and software. He also worked for the company as a consultant at home and abroad. With his Master’s thesis, he shifted his focus to neurology and related medical technologies. In this context, he developed a patented concept for EEG electrodes from the idea to the application.


Helmholtz Enterprise Sponsorship

On October 20, we had the opportunity to present our progress since the beginning of 2021 to reviewers of the Helmholtz Enterprise Program as part of our interim evaluation. We presented our achievements and plans for the future of Metis Neurotec. Thereby, we were able to convince the Helmholtz Association of German Research Centers to continue funding us in the Helmholtz Enterprise Spin-Off Program.

Briefly about Helmholtz Enterprise:
“The Helmholtz Enterprise (HE) spin-off program promotes entrepreneurship and spin-off activities of scientists in the Helmholtz community. Since the establishment of Helmholtz Enterprise in 2005, 167 start-up projects (including HE Plus and FSF) have benefited from the initiative. Of these, more than 95 projects have been successfully founded, 83 percent of which are still operating in the market today.” – Helmholtz Enterprise

We have achieved a lot as the startup Metis Neurotec in the past six months:
  • We have made progress in our AI-powered platform for the treatment of neurological diseases.
  • We have been accepted into the @AHEAD Accelerator program of the @Fraunhofer Gesellschaft
  • We have a platform to network with other startups through BadenCampus
  • We are strong in network building with key individuals and organizations for our startup
  • We empirically support our work throughsurveys and interviews with stakeholders and future customers
  • We have undertaken successful field trials for technical validation
  • We have secured our continued funding
  • We are taking business and scientific advice to build the startup competently

We as Metis Neurotec still have a lot to do and are continuously building our startup thanks to the Helmholtz Enterprise Program.


Finals DemoDay 2021

At the DemoDay 2021 of BadenCampus we were honored with the audience award for our Startup Pitch on November 25, 2021. Our prize was sponsored by BANSBACH GmbH. We presented our startup Metis Neurotec in a pitch as part of the BadenCampus Startup Accelerator competition. On this evening, the 7 finalists presented their startup idea to a renowned jury of investors.

Briefly about BadenCampus
“As an innovation platform, BadenCampus connects start-ups, medium-sized companies, municipalities, talents and scientific institutions. Through joint formats in an inspiring working environment, solutions for business and society are created based on new technologies.”

– BadenCampus

The festive completion of the BadenCampus Startup Accelerator was very successful. We would like to thank Thomas Scheuerle, Tim Weinhold, Günther Kornacker and Florian D. Weber for the whole event and the support.

Our Startup Pitch

Our Travels

Trip of Delegation to London and Oxford

Markus Schinle (Co-founder of Metis Neurotec) traveled to the United Kingdom with the Minister President of Baden-Württemberg, Winfried Kretschmann, from November 6 to 9, 2021, as part of a delegation of politicians, business leaders and scientists led by Baden-Württemberg International to discuss digitalization and AI in healthcare.

“We want to do everything we can to ensure that our good relations with the United Kingdom remain strong, friendly, long-term and resilient. In the future, our ‘BW-UK Office’ will be a point of contact and an anchor for companies, universities and research institutions, SMEs, start-ups or investors.”

– Ministerpräsident Winfried Kretschmann

During our trip, the Minister President officially inaugurated Baden-Württemberg’s new representative office abroad. This office is located in London and will be a contact center for British companies interested in the Germany’s southwest region and vice versa. It thus serves as a door opener for both sides, as the Brexit has made many things more complicated for international companies and trade between Germany and the United Kingdom. In this context, we also visited the University of Oxford with the Harwell Science and Innovation Campus, Francis Crick Institute, King’s College London and Imperial White City Incubator.

Baden-Württemberg is now the first German federal state to have its own representative office in the United Kingdom. This serves to enhance relationships and build new networks and alliances for THELÄND in all countries and regions of the UK – especially also for AI and digitalization in healthcare. This cross-national cooperation brings many advantages to Metis Neurotec as a startup. The potential here lies primarily in the exchange of technologies and with other startups, access to new markets and capital for future international expansion, as well as in networking with international key players who would like to support the startup in the future.

During the delegation trip, we met many high-ranking politicians as well as people from research and industry. We are proud to have contributed to the cooperation and networking between the two countries in business and science.

Our Travels

BadenCampus Accelerator Alumni Day

On the 21st of October, we attended the BadenCampus Startup Accelerator Alumni Day with over 50 other founders. Here, both present and alumni founders of startups within the Accelerator Program gathered at the Badische Staatsbrauerei Rothaus AG in Grafenhausen.

The program at the event included an input from Kristof Schimmele, General Sales Manager of Rothaus, who gave an insight into the traditional company and was afterwards available for Q&A. In addition, Kai Klapdor, CEO of Enit Systems, spoke about “Fundraising from the perspective of a startup” and his own insights and experiences. We founders and startups could benefit from this. Afterwards, a brewery tour with beer tasting and a shared dinner took place. This created a framework for exchanging experiences with other founders, which was very valuable for us. We had very interesting conversations and were able to exchange ideas with both already established and new startups alike.

We would like to thank BadenCampus and the der Badischen Staatsbrauerei Rothaus AG for the event and the opportunity to exchange ideas with other startups!

Source of Content: BadenCampus & Recyda GmbH


Finals – DemoDay BadenCampus Startup Accelerator 2021

We are one of the top 8 startups in this year’s DemoDay 2021, and now we will pitch again for the final title in front of the BadenCampus jury on 11/25. DemoDay 2021 is part of our Startup Accelerator Program with BadenCampus and you are welcome to visit.


Our pre-final pitch about us – Metis Neurotec – has convinced the jury! Now we are looking forward to the grand finale on the 25th November. Here, at the grand finale of the BadenCampus Startup Accelerator, selected startups will pitch in front of a jury of renowned experts in Breisach. At the beginning, the participants can exchange ideas with innovative startups from the deep-tech sector at various booths from 2:00 PM onwards. After a break with food offerings, the final startup pitches will begin at 5:15 PM. We are looking forward to the following award ceremony and the social exchange after the event.

Briefly about BadenCampus:

“As an innovation platform, BadenCampus connects start-ups, medium-sized companies, municipalities, talents and scientific institutions. Through joint formats in an inspiring working environment, solutions for business and society are created based on new technologies.” – BadenCampus

Source of Content: BadenCampus und LinkedIn Event